Deutsche Märkte geschlossen

Agilent Technologies, Inc. (A)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
145,51-1,86 (-1,26%)
Börsenschluss: 04:00PM EDT
145,51 0,00 (0,00%)
Nachbörse: 07:29PM EDT

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

Sektor(en)Healthcare
BrancheDiagnostics & Research
Vollzeitmitarbeiter17.700

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Michael R. McMullenCEO, President & Director1,91M16,94M1961
Mr. Robert W. McMahonSenior VP, CFO and Interim President of Diagnostics & Genomics Group1,08MN/A1969
Mr. Padraig McDonnellChief Operating Officer1,06MN/AN/A
Mr. Henrik Ancher-JensenSenior VP and President of Order Fulfillment & Supply Chain927,44kN/A1965
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corporate ControllerN/AN/A1966
Mr. John KohlSenior Vice President & Chief Information OfficerN/AN/AN/A
Ms. P. Diana ChiuVP, Interim General Counsel & SecretaryN/AN/AN/A
Mr. Dominique P. GrauSenior Vice President of Human Resources & Global Communications936,31kN/A1959
Ms. Allison BallmerSenior Vice President of Strategy & Corporate DevelopmentN/AN/AN/A
Ms. Yvonne MackieMD of UK & Ireland Operations and VP of Human Resources - EuropeN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate Governance

Agilent Technologies, Inc.s ISS Governance QualityScore, Stand 1. März 2024, lautet 7. Die grundlegenden Scores sind Audit: 8, Vorstand: 3, Shareholderrechte: 9, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.